BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4127854)

  • 1. [Prevention and depression of experimental allergic encephalomyelitis by the administration of brain antigens and barbamyl].
    Reber NV
    Patol Fiziol Eksp Ter; 1973; 17(1):65-7. PubMed ID: 4127854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppression of experimental allergic encephalomyelitis with vaccinia-virus-induced anti-brain antibodies (author's transl)].
    Simon J; Hochstein-Mintzel V; Huber HC; Gradl A; Hansert E
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):23-35. PubMed ID: 68632
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of immunological tolerance to brain antigens as a means of specific prevention and treatment of experimental allergic encephalomyelitis].
    Reber NV
    Biull Eksp Biol Med; 1971 Nov; 72(11):69-73. PubMed ID: 5131039
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of chronic-relapsing EAE by basic protein-liposome complexes.
    Strejan GH; Gilbert JJ; St Louis J
    Prog Clin Biol Res; 1984; 146():429-34. PubMed ID: 6201911
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats.
    Swanborg RH; Swierkosz JE; Saieg RG
    J Immunol; 1974 Feb; 112(2):594-600. PubMed ID: 4130692
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of locally retained antigens in chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
    Tabira T; Itoyama Y; Kuroiwa Y
    Prog Clin Biol Res; 1984; 146():43-8. PubMed ID: 6201912
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1974 Jan; 112(1):392-7. PubMed ID: 4130152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of development of experimental allergic encephalomyelitis by encephalitogenic protein].
    Zhitnukhin IuL; Sofronov BN; Beme DKh; Baĭkovskaia MN
    Patol Fiziol Eksp Ter; 1978; (5):55-60. PubMed ID: 83596
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disordered permeability of the hemato-encephalic barrier in the development of allergic processes of the nervous system].
    Zhitnukhin IuL; Sofronov BN
    Patol Fiziol Eksp Ter; 1989; (5):44-7. PubMed ID: 2482476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous allergic sensitivity in experimental allergic encephalomyelitis].
    Zhitnukhin IuL
    Biull Eksp Biol Med; 1973 Jun; 75(6):82-6. PubMed ID: 4778346
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of experimental allergic encephalomyelitis caused by sensitization with Bordetella pertussis combined with cerebral tissue].
    Kanchurin AKh; Kapitonova ME
    Biull Eksp Biol Med; 1971 Sep; 72(9):73-7. PubMed ID: 4329604
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-inflammatory expression of fibronectin (Fn) and Ia in acute experimental allergic encephalomyelitis (EAE): modulation of endothelial cells (EC) in the immune response detected by quantitative immunoperoxidase studies using monoclonal antibodies (MAb).
    Sobel RA; Blanchette BW; Colvin RB
    Prog Clin Biol Res; 1984; 146():81-6. PubMed ID: 6201925
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in clinico-immunological indices of experimental allergic encephalomyelitis after treatment with perftoran].
    Zhitnukhin IuL; Litvinenko IV; Bisaga GN; Odinak MM
    Biull Eksp Biol Med; 1997 Mar; 123(3):315-8. PubMed ID: 9162244
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of myelin lipids in experimental allergic encephalomyelitis.
    Hosein ZZ; Gilbert JJ; Strejan GH
    Prog Clin Biol Res; 1984; 146():49-54. PubMed ID: 6201918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some immunological manifestations of experimental allergic encephalomyelitis (author's transl)].
    Rysková O; Nozicka Z; Vejbora O; Pekárek J
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jan; 31(1):21-9. PubMed ID: 6174247
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
    Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
    Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein.
    Swanborg RH
    J Immunol; 1973 Oct; 111(4):1067-70. PubMed ID: 4728676
    [No Abstract]   [Full Text] [Related]  

  • 20. The blastoid transformation of the lymphocytes from experimental allergic encephalomyelitis guinea pigs.
    Nakano K; Nagai Y; Otani S; Tsumita T
    Jpn J Exp Med; 1971 Apr; 41(2):159-62. PubMed ID: 5313764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.